Biodesix Inc.

NASDAQ: BDSX · Real-Time Price · USD
0.29
-0.01 (-4.26%)
At close: Jun 09, 2025, 3:59 PM

Biodesix Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-42.93M -52.15M -65.45M -43.16M
Depreciation & Amortization
5.46M 5.51M 5.84M 3.18M
Stock-Based Compensation
6.64M 5.37M 5.96M 4.94M
Other Working Capital
-21.52M 15.34M -2.98M -6.86M
Other Non-Cash Items
3.86M 7.09M 13.01M 4.33M
Deferred Income Tax
n/a n/a n/a -2.1M
Change in Working Capital
-21.67M 11.3M -4.34M 4.59M
Operating Cash Flow
-48.65M -22.87M -44.97M -28.22M
Capital Expenditures
-3.23M -23.06M -3.53M -2.55M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-210K -143K -236K -306K
Investing Cash Flow
-3.44M -23.06M -3.53M -2.55M
Debt Repayment
-51K 9.95M 16.5M -15.35M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-3.52M -8.95M -17.15M 269K
Financial Cash Flow
52.05M 29.13M 58.88M 1.26M
Net Cash Flow
-39K -16.8M 10.38M -29.51M
Free Cash Flow
-51.88M -45.93M -48.51M -30.77M